You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 293 No. 14, April 13, 2005 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (10)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Genetic Counseling/ Testing/ Therapy
 •Medical Practice, Other
 •Oncology
 •Breast Cancer
 •Alert me on articles by topic

Confronting Genetic Testing Disparities

Knowledge Is Power

Michael Hall, MD; Olufunmilayo I. Olopade, MBBS

JAMA. 2005;293:1783-1785.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

In 1597, when philosopher Francis Bacon first composed the phrase Nam et ipsa scientia potestas est, "For knowledge itself is power," he could never have imagined its current applicability to reducing disparities in cancer care and prevention in the United States. The landmark Institute of Medicine report Unequal Treatment: Understanding Racial and Ethnic Disparities in Health Care1 revealed that racial- and ethnic-minority patients receive inferior health care compared with white Americans, even when income and insurance inequalities are leveled. The promise of early cancer detection and prevention is within reach as newer technologies become incorporated into medical practice. Unfortunately, new technologies are likely to increase health care disparities even further as they widen the gap between those who already receive the best care and those who do not.

Specifically, the use of genetic counseling and testing for primary cancer prevention is yet another . . . [Full Text of this Article]

Author Affiliations: Departments of Medicine and Human Genetics, University of Chicago, Chicago, Ill.


RELATED ARTICLE

Racial Differences in the Use of BRCA1/2 Testing Among Women With a Family History of Breast or Ovarian Cancer
Katrina Armstrong, Ellyn Micco, Amy Carney, Jill Stopfer, and Mary Putt
JAMA. 2005;293(14):1729-1736.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Genetics Revolution and Primary Care Pediatrics
Cheng et al.
JAMA 2008;299:451-453.
FULL TEXT  

Genetic Testing in Diverse Populations: Are Researchers Doing Enough to Get Out the Correct Message?
Huo and Olopade
JAMA 2007;298:2910-2911.
FULL TEXT  

Cancer Risk Assessment: Examining the Family Physician's Role
Tyler and Snyder
J Am Board Fam Med 2006;19:468-477.
ABSTRACT | FULL TEXT  

Disparities in Genetic Testing: Thinking Outside the BRCA Box
Hall and Olopade
JCO 2006;24:2197-2203.
ABSTRACT | FULL TEXT  

Genetic Testing in an Ethnically Diverse Cohort of High-Risk Women: A Comparative Analysis of BRCA1 and BRCA2 Mutations in American Families of European and African Ancestry
Nanda et al.
JAMA 2005;294:1925-1933.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.